PGI Chandigarh halts treatment of patients from Punjab under Ayushman scheme over pending dues

Published On 2022-08-04 11:45 GMT   |   Update On 2022-08-04 11:45 GMT

Chandigarh: Owing to pending claims exceeding Rs. 15 crores, the Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh has stopped treating patients under the Ayushman Bharat scheme, said officials. The patients can continue to seek treatment at the institute as routine patients by paying the user charges or under other applicable welfare schemes.Also...

Login or Register to read the full article

Chandigarh: Owing to pending claims exceeding Rs. 15 crores, the Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh has stopped treating patients under the Ayushman Bharat scheme, said officials. 

The patients can continue to seek treatment at the institute as routine patients by paying the user charges or under other applicable welfare schemes.

Also Read:Lieutenant General Daljit Singh appointed as honorary Surgeon to President Droupadi Murmu

"PGIMER Chandigarh has been constrained to stop benefits of the Ayushman Bharat scheme for beneficiaries from Punjab over pending claims exceeding Rs 15 crores. However the patients from the state of Punjab can continue to seek treatment at the institute as routine patients by paying the user charges or under other applicable welfare schemes, if so eligible with effect from August 1, 2022," read an official statement.

Ayushman Bharat is a flagship scheme of the Government of India, was launched as recommended by the National Health Policy 2017, to achieve the vision of Universal Health Coverage (UHC).

Ayushman Bharat adopts a continuum of care approach, comprising of two inter-related components, which are -Health and Wellness Centres (HWCs), Pradhan Mantri Jan Arogya Yojana (PM-JAY) and treats patients at nominal to zero/free charges.

Principal Secretary (Health) Ajoy Sharma told The Indian Express that the Finance Department would release an amount of Rs 100 crore on Thursday and the dues of PGI and other hospitals would be cleared and the issue would be resolved.

Earlier on July 26, after the recent issuance of the Ministry's advisory for the preparedness of healthcare institutes for Monkeypox-cases management, the Post Graduate Institute of Medical Education and Research in Chandigarh designated beds in Nehru Hospital and in Nehru hospital extension.

"Due to recent issuance of Ministry advisory for preparedness of the healthcare institutes for management of Monkeypox cases, prima facie PGIMER has designated few beds in Communicable ward of Nehru Hospital and ICU beds in Nehru hospital extension," read an official statement by the PGIMER.

The Monkeypox being a dermatological infestation, the institute have directed the Department of Dermatology to take the lead for examination and management of such suspected cases.

"Any patient suspected of having symptoms simulating to Monkeypox will be directed to dermatology wing of the institute for examination and required testing," the statement read.

Meanwhile, the Department of Virology in PGIMER has also been designated for sample processing and reporting. Competent authorities have also stated that in order to minimise the disease transmission, only the cases needing an active management will be admitted to the hospital while the other stable patients are advised for home isolation.

The NITI Aayog's member (health) Dr VK Paul on Tuesday sought to assert that there was no need for any undue panic and added that it was still important for the country to stay vigilant.

Also Read:PGI Chandigarh gets state of art advanced liver transplant centre

Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News